Dahlqvist R, Ejvinsson G, Schenck-Gustafsson K
Br J Clin Pharmacol. 1980 Apr;9(4):413-8. doi: 10.1111/j.1365-2125.1980.tb01070.x.
1 Thirty patients on maintenance digoxin therapy and admitted for cardioversion of atrial fibrillation were closely monitored with regard to plasma levels of digoxin and quinidine. 2 Seventeen of these patients were kept on maintenance digoxin therapy. After an initial lag period of 6 to 18 h after the addition of quinidine their digoxin levels started to increase and had increased by between 20 and 330% after 3 days on quinidine. Side-effects attributed to the raised digoxin concentration occurred in 6 of these patients. 3 As studied in 5 of these 17 patients the renal clearance of digoxin decreased markedly when quinidine was added to the therapy. There was also a slight but significant reduction in creatinine clearance (n = 4). 4 In 13 patients digoxin was discontinued 36 h prior to the first quinidine dose. Also in these patients digoxin plasma levels increased significantly. 5 It is concluded that quinidine causes an unpredictably large increase in plasma digoxin and that this effect is probably at least initially to a large part due to a redistribution of digoxin in the body. The relative contributions of re-distribution and impaired renal clearance of digoxin to the increase in digoxin steady-state levels are presently unknown. 6 It is recommended that close monitoring of digoxin concentration and appropriate reduction of the maintenance dose is undertaken when quinidine is to be given to patients on digitalis therapy.
对30例正在接受地高辛维持治疗且因房颤复律而入院的患者,密切监测其地高辛和奎尼丁的血浆水平。
其中17例患者继续接受地高辛维持治疗。在加用奎尼丁后的最初6至18小时的延迟期后,他们的地高辛水平开始升高,在使用奎尼丁3天后升高了20%至330%。这些患者中有6例出现了归因于地高辛浓度升高的副作用。
在这17例患者中的5例进行的研究中,当在治疗中加用奎尼丁时,地高辛的肾清除率显著降低。肌酐清除率也有轻微但显著的降低(n = 4)。
在13例患者中,在首次给予奎尼丁剂量前36小时停用了地高辛。在这些患者中,地高辛血浆水平也显著升高。
得出的结论是,奎尼丁会导致血浆地高辛出现不可预测的大幅升高,并且这种效应可能至少在最初很大程度上是由于地高辛在体内的重新分布。目前尚不清楚地高辛重新分布和肾清除受损对其稳态水平升高的相对贡献。
建议在对接受洋地黄治疗的患者给予奎尼丁时,密切监测地高辛浓度并适当减少维持剂量。